View More Recent Stories
-
BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform
-
Regeneron (REGN) Reiterated Outperform at BMO
-
BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform
-
BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform
-
Declining Lucentis Market Share Bodes Well for Regeneron's (REGN) Eylea -BMO
-
BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform

